ImmuneOnco Biopharmaceuticals (Shanghai) Inc

01541

Company Profile

  • Business description

    ImmuneOnco Biopharmaceuticals (Shanghai) Inc is a science-driven biotechnology company dedicated to the development of immuno-oncology therapies. It is one of the few biotechnology companies globally adopting a systematic approach to harness both the innate and adaptive immune systems. It has developed a rich pipeline of 14 drug candidates with eight ongoing clinical programs, featured by a comprehensive innate-immunity-based asset portfolio. Its pipeline reflects its extensive understanding of the frontiers of cancer biology and immunology and its expertise in turning scientific research into drug candidates.

  • Contact

    1000 Zhangheng Road
    Unit 15, China (Shanghai) Pilot Free Trade Zone
    Pudong New Area
    Shanghai
    CHN

    T: +86 2138016387

    https://cn.immuneonco.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    156

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,773.0029.400.34%
CAC 407,696.054.500.06%
DAX 4023,985.4747.75-0.20%
Dow JONES (US)43,819.27432.431.00%
FTSE 1008,798.640.27-0.00%
HKSE24,072.28211.87-0.87%
NASDAQ20,273.46105.550.52%
Nikkei 22540,487.39336.600.84%
NZX 50 Index12,602.8219.230.15%
S&P 5006,173.0732.050.52%
S&P/ASX 2008,542.3028.100.33%
SSE Composite Index3,444.4320.200.59%

Market Movers